Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jered C Garrison

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Bioconjugate Chemistry|August 21, 2008
Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer modelJered C Garrison, Tammy L Rold, Gary L Sieckman, et al.
Bioconjugate Chemistry|September 24, 2008
Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vectorWael R Abd-Elgaliel, Fabio Gallazzi, Jered C Garrison, et al.
Molecular Pharmaceutics|March 18, 2025
Enhanced Retention of NTSR1-Targeted Radionuclide Therapeutics via Covalent Inhibitors in Pancreatic, Colorectal, and Prostate Cancer ModelsWenting Zhang, Wei Fan, Katie Brake, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2007
[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissuesAdam F Prasanphanich, Prasant K Nanda, Tammy L Rold, et al.
European Journal of Medicinal Chemistry|June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapySatish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
Biomaterials|September 25, 2018
Bioimaging predictors of rilpivirine biodistribution and antiretroviral activitiesBrendan M Ottemann, Austin J Helmink, Wenting Zhang, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Bioconjugate Chemistry|August 21, 2008
Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer modelJered C Garrison, Tammy L Rold, Gary L Sieckman, et al.
Bioconjugate Chemistry|September 24, 2008
Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vectorWael R Abd-Elgaliel, Fabio Gallazzi, Jered C Garrison, et al.
Molecular Pharmaceutics|March 18, 2025
Enhanced Retention of NTSR1-Targeted Radionuclide Therapeutics via Covalent Inhibitors in Pancreatic, Colorectal, and Prostate Cancer ModelsWenting Zhang, Wei Fan, Katie Brake, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2007
[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissuesAdam F Prasanphanich, Prasant K Nanda, Tammy L Rold, et al.
European Journal of Medicinal Chemistry|June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapySatish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
Biomaterials|September 25, 2018
Bioimaging predictors of rilpivirine biodistribution and antiretroviral activitiesBrendan M Ottemann, Austin J Helmink, Wenting Zhang, et al.
Pageof 4